Variant report

Variant	nsv821498
Chromosome Location	chr10:1658596-1660016
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 133 )
Associated
traits (count: 56 )

Variant overlapped rSNPs/rCNVs (count:133 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs183809961	chr10:1658629-1658630	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs569035330	chr10:1658640-1658641	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs531675009	chr10:1658649-1658650	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs112871995	chr10:1658650-1658651	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs112657935	chr10:1658655-1658656	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs548241066	chr10:1658656-1658657	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs112325680	chr10:1658667-1658668	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs112161953	chr10:1658669-1658670	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs112226211	chr10:1658676-1658677	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs369628965	chr10:1658728-1658729	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs113104091	chr10:1658742-1658743	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs3861052	chr10:1658747-1658748	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs3062752	chr10:1658761-1658762	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs111732389	chr10:1658762-1658763	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs111383286	chr10:1658768-1658769	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs568657767	chr10:1658771-1658772	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs534094598	chr10:1658778-1658779	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs373543019	chr10:1658798-1658799	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs377011727	chr10:1658809-1658810	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs200882494	chr10:1658819-1658820	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs373383334	chr10:1658820-1658821	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs571057575	chr10:1658838-1658839	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs377460693	chr10:1658854-1658855	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs539471203	chr10:1658866-1658867	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs112244904	chr10:1658932-1658933	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs370278664	chr10:1658951-1658952	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs4880886	chr10:1658955-1658956	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs74406143	chr10:1659023-1659024	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs11596477	chr10:1659024-1659025	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs202017148	chr10:1659040-1659041	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs572213402	chr10:1659048-1659049	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs12778230	chr10:1659053-1659054	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs540858113	chr10:1659059-1659060	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs564452483	chr10:1659061-1659062	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs563801307	chr10:1659072-1659073	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs12772184	chr10:1659082-1659083	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs12778256	chr10:1659085-1659086	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs375313203	chr10:1659094-1659095	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs556364925	chr10:1659096-1659097	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs7072693	chr10:1659115-1659116	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs370433400	chr10:1659130-1659131	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs12355070	chr10:1659131-1659132	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs12778439	chr10:1659145-1659146	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs12773118	chr10:1659153-1659154	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs12772366	chr10:1659156-1659157	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs60736342	chr10:1659178-1659179	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs12773133	chr10:1659179-1659180	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs113390294	chr10:1659188-1659189	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs112240529	chr10:1659202-1659203	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs113215078	chr10:1659207-1659208	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:56)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Breast cancer	20409316	CNVD
Gastric adenocarcinoma	19115996	CNVD
Pilocytic astrocytoma	18622384	CNVD
Pilomyxoid astrocytoma	18622384	CNVD
Breast cancer	17133270	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Cancer	21129771	CNVD
Sudden cardiac death	19188705	CNVD
Digeorge syndrome	22283845	CNVD
Colorectal cancer	20709793	CNVD
Wilms tumour	19047088	CNVD
Hepatocellular carcinoma	16750200	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Barakat syndrome	22470819	CNVD
Melanoma	18172304	CNVD
Ovarian cancer	21720365	CNVD
Autism	18414403	CNVD
Malignant melanoma	18718029	CNVD
Breast cancer	22032731	CNVD
Medulloblastoma	16783165	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Melanoma	17363583	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Breast cancer	21785460	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	21509527	CNVD
Prostate cancer	18632612	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Autism	22543975	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:24 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:1651800-1671200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr10:1654600-1659600	Weak transcription	HUES6 Cell Line	embryonic stem cell
3	chr10:1654800-1659000	Weak transcription	H1 Cell Line	embryonic stem cell
4	chr10:1654800-1659000	Weak transcription	HUES48 Cell Line	embryonic stem cell
5	chr10:1654800-1659000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
6	chr10:1655400-1659800	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr10:1655400-1660000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
8	chr10:1657800-1658800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
9	chr10:1658000-1667600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr10:1658200-1659200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr10:1658600-1658800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
12	chr10:1658800-1659200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr10:1659000-1659200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
14	chr10:1659000-1660200	Enhancers	H1 Cell Line	embryonic stem cell
15	chr10:1659000-1660400	Enhancers	HUES48 Cell Line	embryonic stem cell
16	chr10:1659000-1660400	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr10:1659200-1659400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr10:1659200-1671800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
19	chr10:1659600-1660000	Enhancers	HUES6 Cell Line	embryonic stem cell
20	chr10:1659800-1660200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
21	chr10:1659800-1660400	Enhancers	Primary B cells from peripheral blood	blood
22	chr10:1660000-1660400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr10:1660000-1660600	Enhancers	iPS-18 Cell Line	embryonic stem cell
24	chr10:1660000-1660600	Bivalent Enhancer	Primary B cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links